×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

PROGRAMME:

Modérateurs: Fabrice Lécuru et Manuel Rodrigues
19:00
Spécificités des soins de support en ovaire : gestion de la carcinose symptomatique et pré-habilitation en néoadjuvant
Carole Bouleuc
 
 
19:15
Quel avenir à l’immunothérapie dans les cancers de l’ovaire ?
Audrey Bellesoeur
 
19:30
Traitement des récidives sous PARPi
Manuel Rodrigues
 
19:45
Chirurgie de la récidive : au-delà des essais GOG213, SOC1 & DESKTOP
Fabrice Lécuru
 
 
20:00
Débat/Discussion - Réponses aux questions
 
 
  
Shooting date : 2022-03-22
Last update : 2022-03-24
1 comment
Join the Discussion
  • johanne L. bonjour comment fait-on pour s inscrire ?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
    Honolulu : Monday, October 4th 2021 from 07am to 08:30am (GMT+2)
    San Francisco : Monday, October 4th 2021 from 10am to 11:30am (GMT+2)
    New York : Monday, October 4th 2021 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Monday, October 4th 2021 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Monday, October 4th 2021 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Monday, October 4th 2021 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Monday, October 4th 2021 from 07pm to 08:30pm (GMT+2)
    Istanbul : Monday, October 4th 2021 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Monday, October 4th 2021 from 09pm to 10:30pm (GMT+2)
    Bangkok : Tuesday, October 5th 2021 from 12am to 01:30am (GMT+2)
    Shanghai : Tuesday, October 5th 2021 from 01am to 02:30am (GMT+2)
    Tokyo : Tuesday, October 5th 2021 from 02am to 03:30am (GMT+2)
    Sydney : Tuesday, October 5th 2021 from 04am to 05:30am (GMT+2)
    Wellington : Tuesday, October 5th 2021 from 06am to 07:30am (GMT+2)

    Cancer de l'ovaire : observance long terme sous inhibiteurs de PARP

    Episode 1

    Share
    Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, November 21st 2023 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, November 21st 2023 from 09am to 10:30am (GMT+1)
    New York : Tuesday, November 21st 2023 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, November 21st 2023 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, November 21st 2023 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, November 21st 2023 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, November 22nd 2023 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, November 22nd 2023 from 05am to 06:30am (GMT+1)

    Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

    Share
    Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, October 10th 2023 from 07:30am to 09am (GMT+2)
    San Francisco : Tuesday, October 10th 2023 from 10:30am to 12pm (GMT+2)
    New York : Tuesday, October 10th 2023 from 01:30pm to 03pm (GMT+2)
    Buenos Aires : Tuesday, October 10th 2023 from 02:30pm to 04pm (GMT+2)
    Reykjavik : Tuesday, October 10th 2023 from 05:30pm to 07pm (GMT+2)
    London / Dublin : Tuesday, October 10th 2023 from 06:30pm to 08pm (GMT+2)
    Paris / Berlin : Tuesday, October 10th 2023 from 07:30pm to 09pm (GMT+2)
    Istanbul : Tuesday, October 10th 2023 from 08:30pm to 10pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 10th 2023 from 09:30pm to 11pm (GMT+2)
    Bangkok : Wednesday, October 11th 2023 from 12:30am to 02am (GMT+2)
    Shanghai : Wednesday, October 11th 2023 from 01:30am to 03am (GMT+2)
    Tokyo : Wednesday, October 11th 2023 from 02:30am to 04am (GMT+2)
    Sydney : Wednesday, October 11th 2023 from 04:30am to 06am (GMT+2)
    Wellington : Wednesday, October 11th 2023 from 06:30am to 08am (GMT+2)

    La prise en charge du cancer de l’ovaire chez la personne âgée : expériences croisées du CGFL ...

    Cycle d'enseignement sur le cancer de l'ovaire - Deuxième session

    Share
    Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, February 7th 2024 from 07am to 08:30am (GMT+1)
    San Francisco : Wednesday, February 7th 2024 from 09am to 10:30am (GMT+1)
    New York : Wednesday, February 7th 2024 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Wednesday, February 7th 2024 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Istanbul : Wednesday, February 7th 2024 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, February 7th 2024 from 09pm to 10:30pm (GMT+1)
    Bangkok : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
    Shanghai : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
    Tokyo : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
    Sydney : Thursday, February 8th 2024 from 03am to 04:30am (GMT+1)
    Wellington : Thursday, February 8th 2024 from 05am to 06:30am (GMT+1)

    Toxicités hématologiques des inhibiteurs de PARP

    Regards croisés oncologue-hématologue-interniste

    Share
    Scroll Up